Casper Joseph Michael bought NRXP
January 27, 2026 · Form 4 insider transaction
Casper Joseph Michael bought 100,000 shares of NRx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 21 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderCasper Joseph Michael
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 27, 2026
Filing dateFebruary 17, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents stock options ("Options") granted pursuant to the Issuer's 2021 Omnibus Incentive Plan. 33.3% of the Options shall vest on June 1, 2026, 33.3% shall vest on December 1, 2026, and the remaining 33.3% shall vest on December 1, 2027.